Required fields are marked * Your rating *
But the move wouldnt solve all of the issues
The combination provides more growth hormone signaling to more receptors, amplifying tissue repair beyond what either approach achieves alone
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
To maximize the healing benefits of BPC-157 for an injury, consider timing your dosage around moments when you experience elevated physical activity or exertion in that area
One study found positive effects on knee pain in 14 out of 16 patients